Homoeopathy debate hurts Boiron in France

3 May 2019 - Deborah Wilkes

Archived

Boiron said sales in its home market of France fell by 9.3% in the first quarter of 2019 as the country debated whether homoeopathy should be delisted from reimbursement.

Click tags below for more information on topics:

Boiron Homeopathy

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: